Product
Spikogen/Covax-19
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase 2b Study to Assess the Effect of Dose Interval on the Effectiveness of a Protein-based Covid-19 Vaccine (Spikogen® Vaccine)Status: Active (not recruiting), Estimated PCD: 2023-02-23